INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma

Martin J. van den Bent, Marica Eoli, Juan Manuel Sepúlveda-Sánchez, +22

Neuro-Oncology

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers

Emmanuel Seront, Sylvie Rottey, Brieuc Sautois, +16

Annals of Oncology

UrologyGenitourinary CancerMedicinePhase Ii StudyCancer Treatment +5

Long-term survival after glioblastoma resection: hope despite poor prognosis factors

Emmanuel Costa, Tévi Morel Lawson, Julie Lelotte, +5

Journal of Neurosurgical Sciences

Health-related quality of life and cognitive failures in patients with lower-grade gliomas treated with radiotherapy

Dario Di Perri, S. Jmil, Tévi Morel Lawson, +3

Cancer/Radiothérapie

Quality Of LifeNeuro-oncologyLife AssessmentLower-grade GliomasRadiation Therapy +9

Safety and Pharmacokinetics of Sorafenib Combined With Capecitabine in Patients With Advanced Solid Tumors: Results of a Phase 1 Trial

Ahmad Awada, Thierry Gil, Nicolas Whenham, +9

The Journal of Clinical Pharmacology

OncologySorafenib CombinedMg Bid SorafenibPharmacologyAdvanced Solid Tumors +8

Dietary betaine reduces plasma homocysteine concentrations and improves bone strength in laying hens

M. B. M. Maidin, H. A. McCormack, Peter W.F. Wilson, +3

British Poultry Science

NutritionDietary BetaineFeed AdditivePublic HealthBone Strength +18

Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma

Paul M. Clément, Linda Dirven, Marica Eoli, +19

European Journal of Cancer

Neuro-oncologyNeurological FunctioningGliomaHealth-related QualityMedicine +9

Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics

Georges Chehade, Tévi Morel Lawson, Julie Lelotte, +7

Acta Neurochirurgica

Neuro-oncologyTumoral PathologyMedicinePathologyBrain Tumor Biology +9

Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy

Jean‐Pascal Machiels, Aline van Maanen, Jean‐Marie Vandenbulcke, +19

The Oncologist

LTBK-04 FIRST RESULTS OF THE RANDOMIZED PHASE II STUDY ON DEPATUX –M ALONE, DEPATUX-M IN COMBINATION WITH TEMOZOLOMIDE AND EITHER TEMOZOLOMIDE OR LOMUSTINE IN RECURRENT EGFR AMPLIFIED GLIOBLASTOMA: FIRST REPORT FROM INTELLANCE 2/EORTC TRIAL 1410

Martin J. van den Bent, Marica Eoli, Juan Manuel Sepúlveda-Sánchez, +21

Neuro-Oncology

PathologyImmunotherapeuticsHigh-grade GliomasGliomaNeuro-oncology +17